M Zander, S Madsbad, JL Madsen, JJ Holst - The Lancet, 2002 - Elsevier 20 patients with type 2 diabetes were alternately assigned continuous
subcutaneous infusion of GLP-1 (n=10) or saline (n=10) for 6 weeks. Before (week
0) and at weeks 1 and 6, they underwent β-cell function tests ... Cited by 618 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org [PDF] MM Engelgau, KM Narayan, WH Herman - Diabetes Care, 2000 - Am Diabetes Assoc In 1997, nearly 16 million people in the US had diabetes (1,2). Of this
population, 10.3 million were diag- nosed and 5.4 million were undiagnosed
(1,2). In the future, these numbers are expected to increase substantially ... Cited by 222 - Related articles - All 9 versions
M Ravid, D Brosh, D Ravid-Safran, Z Levy, R … - Archives of Internal Medicine, 1998 - archinte.highwire.org Patients and Methods A prospective, long-term follow-up study was conducted on
574 patients, aged 40 to 60 years, with recent onset of type 2 diabetes
mellitus. Patients were initially normotensive and had normal renal ... Cited by 223 - Related articles - BL Direct - All 4 versions
- ►eje-online.org [PDF] E Diamanti-Kandarakis, C Kouli, T Tsianateli, … - European Journal of Endocrinology, 1998 - EFES Evidence suggests that insulin resistance and hyperinsulinaemia are associated
with ovarian hyper- androgenism and menstrual irregularities in polycystic ovary
syndrome (PCOS). Sixteen obese women with PCOS on a weight-maintaining diet ... Cited by 212 - Related articles - BL Direct - All 8 versions
N Ismail, B BECKER, P STRZELCZYK, E RITZ - Kidney international, 1999 - nature.com Renal disease and hypertension in non–insulin-dependent diabetes mellitus.
Recent epidemiologic data demonstrate a dramatic increase in the incidence of
end-stage renal disease (ESRD) in patients with non-insulin-dependent ... Cited by 182 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org KB Degn, CB Juhl, J Sturis, G Jakobsen, B … - Diabetes, 2004 - Am Diabetes Assoc Glucagon-like peptide 1 (GLP-1) is potentially a very attractive agent for
treating type 2 diabetes. We explored the effect of short-term (1 week)
treatment with a GLP-1 derivative, liraglutide (NN2211), on 24-h dynamics ... Cited by 170 - Related articles - BL Direct - All 8 versions
S Mäkimattila, K Nikkilä, H Yki-Järvinen - Diabetologia, 1999 - Springer Despite a good initial response to insulin therapy in patients with Type II
(non-insulin-dependent) diabe- tes mellitus, long-term treatment results are
often less satisfactory [1]. The poor treatment results have been ... Cited by 163 - Related articles - BL Direct - All 5 versions
- ►nih.gov J Costa, M Borges, C David, AV Carneiro - British Medical Journal, 2006 - bmj.com The prevalence of diabetes mellitus is increasing. Up to 218 mil- lion people
are likely to have the disease by 2010.1 The current understanding is that type
2 diabetes mellitus is a metabolic dis- order, defined by hyperglycaemia, ... Cited by 146 - Related articles - BL Direct - All 9 versions
EK Hoogeveen, PJ Kostense, A Jager, RJ … - Kidney international, 1998 - nature.com Microalbuminuria (MA) is a strong predictor of cardiovascular disease, but its
causes are incompletely understood. Hyperhomocysteinemia is a recently
recognized risk factor for cardiovascular disease independent of ... Cited by 131 - Related articles - BL Direct - All 9 versions
B Gaster, IB Hirsch - Archives of Internal Medicine, 1998 - archinte.highwire.org Type 2 diabetes is 8 to 10 times more common than type 1 diabetes, but no single
large trial has established that improved glycemic control can prevent
complications in type 2 diabetes. We have reviewed the results of the ... Cited by 128 - Related articles - All 4 versions
